tiprankstipranks
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC

Cartesian Therapeutics (RNAC) Income Statement

1,060 Followers

Cartesian Therapeutics Income Statement

Last quarter (Q4 2023), Cartesian Therapeutics's total revenue was $8.27M, a decrease of -50.78% from the same quarter last year. In Q4, Cartesian Therapeutics's net income was $-177.66M. See Cartesian Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 26.00M$ 26.00M$ 110.78M$ 85.08M$ 16.60M$ 6.68M
Cost of Revenue
------
Gross Profit
$ 26.00M$ 26.00M$ 110.78M$ 85.08M--
Operating Expense
$ 112.42M$ 112.42M$ 96.24M$ 89.67M$ 73.42M$ 59.13M
Operating Income
$ -86.42M$ -86.42M$ 14.54M$ -4.60M$ -56.82M$ -52.45M
Net Non Operating Interest Income Expense
$ -108.00K$ -2.83M$ -3.03M$ -2.80M$ -1.56M$ -1.52M
Other Income Expense
$ 133.92M$ 131.20M$ -23.29M$ 2.32M$ -10.50M$ -1.38M
Pretax Income
$ -238.71M$ -238.71M$ 34.77M$ -9.72M$ -68.88M$ -55.35M
Tax Provision
$ -19.00M$ -19.00M$ -609.00K$ 15.97M$ 0.00-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -219.71M$ -219.71M$ 35.38M$ -25.69M$ -68.88M$ -55.35M
Basic EPS
$ -1.39$ -1.66$ 0.24$ -0.22$ -0.68$ -1.22
Diluted EPS
$ -1.39$ -1.66$ 0.10$ -0.22$ -0.68$ -1.22
Basic Average Shares
$ 620.44M$ 155.11M$ 144.76M$ 114.33M$ 101.20M$ 45.55M
Diluted Average Shares
$ 620.44M$ 155.11M$ 145.87M$ 114.33M$ 101.20M$ 45.55M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 112.42M$ 112.42M$ 96.24M$ 89.67M$ 73.42M$ 59.13M
Net Income From Continuing And Discontinued Operation
$ -219.71M$ -219.71M$ 35.38M$ -25.69M$ -68.88M$ -55.35M
Normalized Income
$ -25.51M$ -51.45M$ 34.16M-$ -58.29M$ -55.28M
Interest Expense
----$ 1.56M$ 1.52M
EBIT
$ -235.88M$ -235.88M$ 37.80M$ -6.92M$ -67.32M$ -53.83M
EBITDA
$ -226.73M$ -235.03M$ 39.94M$ -4.49M$ -66.59M$ -53.10M
Currency in USD

Cartesian Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis